Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microcystis aeruginosa is a ubiquitous species of freshwater cyanobacteria recognized for its ability to form harmful algal blooms (HABs) in nutrient-rich aquatic environments. While categorized as a target in environmental toxicology and databases like ChEMBL, it is a complex prokaryotic organism rather than a discrete therapeutic molecule or receptor. The primary clinical significance of M. aeruginosa lies in its production of microcystins, which are potent cyclic heptapeptide hepatotoxins that inhibit eukaryotic protein phosphatases 1 and 2A. Human exposure to these toxins via contaminated water can lead to acute liver failure, gastrointestinal distress, and chronic health issues, including potential oncogenesis. Environmental control agents, such as hydrogen peroxide and copper-based algaecides, interact with the organism by inducing oxidative stress or disrupting photosynthetic pathways to mitigate bloom formation. Additionally, certain cellular components like phycobiliproteins have been identified as allergens capable of inducing IgE-mediated respiratory responses in susceptible individuals.
Algaecides and chemical disinfectants target the organism through the induction of oxidative damage, inhibition of the photosynthetic apparatus (e.g., Photosystem II), or physical disruption of the cell membrane, ultimately leading to cell lysis and death.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microcystis aeruginosa (M. aeruginosa).